Options Brief: Immucor
Shares of Immucor (NASDAQ: BLUD) are lower on the session by 0.19%, trading at $26.60.
Overall call volume is now running at 4.08x the daily average, with 2% of all calls traded being purchases on the offer. 1,216 contracts have traded on the session so far.
Immucor, Inc. develops, manufactures and sells a line of reagents and automated systems that detect and identify certain properties of the cell and serum components of human blood for the purpose of blood transfusion.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Options